Book Cover
Home  |   Chemicals & Materials   |  Animal-sourced Squalene Market

Animal-sourced Squalene Market Size, Share, Growth, and Industry Analysis, By Type (C Level,Director Level), By Application (Cosmetics,Food Supplements,Healthcare), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Animal-sourced Squalene Market Overview

The global Animal-sourced Squalene Market size is projected to grow from USD 135.57 million in 2026 to USD 144.13 million in 2027, reaching USD 234.46 million by 2035, expanding at a CAGR of 6.31% during the forecast period.

In 2024, global animal-sourced squalene production reached approximately 18,500 metric tons, with over 65 percent derived from shark liver oil and 35 percent from deep-sea fish sources. Cosmetics accounted for 47 percent of global demand, food supplements 33 percent, and healthcare 20 percent. Asia-Pacific contributed 40 percent of global consumption, Europe 27 percent, North America 25 percent, and Middle East & Africa 8 percent. More than 1,500 patents were filed globally between 2023 and 2024 focused on refining extraction methods and improving purity levels beyond 98 percent, supporting demand growth in cosmetics and pharmaceuticals.

The United States accounted for 21 percent of global demand in 2024, consuming nearly 3,900 metric tons of animal-sourced squalene. Cosmetics represented 49 percent of U.S. demand, equal to 1,911 metric tons, food supplements 34 percent with 1,326 metric tons, and healthcare 17 percent with 663 metric tons. Imports from Asia accounted for 62 percent of the U.S. supply, while domestic marine industries contributed 38 percent. More than 70 cosmetic brands integrated animal-sourced squalene formulations into skincare lines in 2024. Demand from dietary supplement manufacturers rose by 18 percent year-on-year, reflecting growing consumer interest in omega-rich oils.

Global Animal-sourced Squalene Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: 47 percent of demand came from cosmetics in 2024.
  • Major Market Restraint: 29 percent of supply faced sustainability restrictions.
  • Emerging Trends: 65 percent of production derived from shark liver oil globally.
  • Regional Leadership: Asia-Pacific accounted for 40 percent of consumption in 2024.
  • Competitive Landscape: 18,500 metric tons of animal-sourced squalene were produced globally in 2024.
  • Market Segmentation: Food supplements represented 33 percent, equal to 6,100 metric tons.
  • Recent Development: 1,500 patents were filed globally between 2023–2024.

In 2024, the animal-sourced squalene market recorded global consumption of 18,500 metric tons. Cosmetics dominated with 47 percent, totaling 8,700 metric tons, with Asia-Pacific and Europe leading demand for skincare applications. Food supplements accounted for 33 percent with 6,100 metric tons, fueled by growing health-conscious consumer bases in North America and Asia-Pacific. Healthcare contributed 20 percent, or 3,700 metric tons, largely in vaccine adjuvants and immune-boosting formulations. Asia-Pacific led global consumption with 7,400 metric tons, Europe followed with 5,000 metric tons, North America 4,600 metric tons, and Middle East & Africa 1,500 metric tons.

Animal-sourced Squalene Market Dynamics

DRIVER

"Increasing cosmetic industry reliance on squalene for premium formulations."

In 2024, cosmetics accounted for 47 percent of demand, equal to 8,700 metric tons. Asia-Pacific consumed 3,200 metric tons for cosmetics, Europe 2,600 metric tons, North America 2,100 metric tons, and Middle East & Africa 800 metric tons. Over 1,200 cosmetic brands globally adopted animal-sourced squalene in 2024. Anti-aging creams accounted for 36 percent of cosmetic usage, moisturizers 32 percent, and serums 22 percent. Demand for premium skincare products increased by 15 percent in 2024, directly boosting squalene consumption.

RESTRAINT

"Sustainability restrictions on shark-derived squalene."

Shark liver oil accounted for 65 percent of production, equal to 12,000 metric tons in 2024. However, sustainability regulations restricted 29 percent of global supply. In Europe, 35 percent of shark-based squalene imports faced trade barriers, while North America restricted 18 percent of imports. Asia-Pacific saw 22 percent of fisheries subjected to conservation quotas, limiting production. Consumer pressure also increased, with 41 percent of surveyed buyers favoring sustainable alternatives.

OPPORTUNITY

"Rising adoption in healthcare applications such as vaccine adjuvants".

Healthcare applications consumed 3,700 metric tons in 2024, equal to 20 percent of demand. Asia-Pacific accounted for 1,400 metric tons, North America 1,100 metric tons, Europe 900 metric tons, and Middle East & Africa 300 metric tons. Squalene was used in more than 25 percent of adjuvant-based vaccines worldwide in 2024, supporting immune response efficiency. Pharmaceutical firms expanded usage in liver supplements and cardiovascular products, representing 38 percent of healthcare demand.

CHALLENGE

"Volatile supply chain and price fluctuations."

In 2024, 65 percent of squalene supply was derived from shark liver, with catches concentrated in Asia-Pacific fisheries. Annual production fluctuated by 12 percent due to seasonal availability, impacting pricing. Europe reported 15 percent cost volatility in imports, while North America experienced 18 percent variability. Supply chain disruptions during 2023–2024 delayed delivery of over 1,200 metric tons globally. Fluctuations affected cosmetic companies most, with 28 percent reporting shortages in 2024.

Animal-sourced Squalene Market Segmentation

The animal-sourced squalene market is segmented by type and application. By type, C level represented 56 percent of demand in 2024, and director level 44 percent. By application, cosmetics accounted for 47 percent, food supplements 33 percent, and healthcare 20 percent.

Global Animal-sourced Squalene Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

BY TYPE

C Level: C level squalene represented 56 percent of demand in 2024, equal to 10,300 metric tons. Asia-Pacific consumed 4,000 metric tons, North America 2,600 metric tons, Europe 2,200 metric tons, and Middle East & Africa 1,500 metric tons. Preferred in cosmetics for purity levels reaching 98 percent.

C Level Animal-sourced Squalene is estimated at USD 76.52 million in 2025 with a 60% share, projected to reach USD 124.80 million by 2034 at a CAGR of 6.31%, supported by expanding demand in premium healthcare and cosmetic formulations.

Top 5 Major Dominant Countries in the C Level Segment

  • United States: USD 22.95 million in 2025 with 30% share, projected to hit USD 37.44 million by 2034 at 6.31% CAGR, driven by strong cosmetic and healthcare sectors.
  • China: USD 15.30 million in 2025 with 20% share, projected at USD 24.96 million by 2034 at 6.31% CAGR, led by growing demand in skincare products.
  • Japan: USD 9.18 million in 2025 with 12% share, forecasted to reach USD 14.98 million by 2034 at 6.31% CAGR, supported by beauty and personal care markets.
  • Germany: USD 7.65 million in 2025 with 10% share, projected at USD 12.48 million by 2034 at 6.31% CAGR, driven by pharmaceutical applications.
  • France: USD 6.12 million in 2025 with 8% share, forecasted to hit USD 9.98 million by 2034 at 6.31% CAGR, supported by luxury cosmetics demand.

Director Level: Director level squalene accounted for 44 percent of demand in 2024, equal to 8,200 metric tons. Asia-Pacific consumed 3,400 metric tons, Europe 2,000 metric tons, North America 2,000 metric tons, and Middle East & Africa 800 metric tons. Used widely in food supplements and healthcare for stable quality.

Director Level Animal-sourced Squalene is valued at USD 51.01 million in 2025 with a 40% share, expected to reach USD 83.20 million by 2034 at a CAGR of 6.31%, fueled by adoption in dietary supplements and general healthcare.

Top 5 Major Dominant Countries in the Director Level Segment

  • United States: USD 15.30 million in 2025 with 30% share, projected to reach USD 24.96 million by 2034 at 6.31% CAGR, supported by dietary supplement manufacturers.
  • China: USD 10.20 million in 2025 with 20% share, forecasted at USD 16.64 million by 2034 at 6.31% CAGR, driven by rising functional food industries.
  • Japan: USD 6.12 million in 2025 with 12% share, projected to hit USD 9.98 million by 2034 at 6.31% CAGR, supported by nutraceutical usage.
  • Germany: USD 5.10 million in 2025 with 10% share, expected at USD 8.32 million by 2034 at 6.31% CAGR, driven by health-focused dietary trends.
  • South Korea: USD 4.08 million in 2025 with 8% share, projected at USD 6.66 million by 2034 at 6.31% CAGR, fueled by skincare-driven supplement growt

BY APPLICATION

Cosmetics: Cosmetics accounted for 47 percent of consumption in 2024, equal to 8,700 metric tons. Asia-Pacific led with 3,200 metric tons, followed by Europe with 2,600, North America 2,100, and Middle East & Africa 800.

Cosmetics applications are projected at USD 57.39 million in 2025 with a 45% share, expected to hit USD 93.60 million by 2034 at a CAGR of 6.31%, driven by premium skincare and anti-aging formulations.

Top 5 Major Dominant Countries in Cosmetics Application

  • United States: USD 17.21 million in 2025, projected at USD 28.08 million by 2034 at 6.31% CAGR, led by luxury cosmetic brands.
  • China: USD 11.48 million in 2025, forecasted at USD 18.74 million by 2034 at 6.31% CAGR, supported by expanding skincare consumption.
  • Japan: USD 6.89 million in 2025, projected at USD 11.24 million by 2034 at 6.31% CAGR, driven by personal care innovation.
  • France: USD 5.74 million in 2025, forecasted at USD 9.36 million by 2034 at 6.31% CAGR, fueled by luxury cosmetic exports.
  • South Korea: USD 5.74 million in 2025, projected at USD 9.36 million by 2034 at 6.31% CAGR, supported by K-beauty trends.

Food Supplements: Food supplements represented 33 percent of demand, equal to 6,100 metric tons in 2024. North America accounted for 2,200 metric tons, Asia-Pacific 2,000, Europe 1,400, and Middle East & Africa 500.

Food Supplements are valued at USD 44.64 million in 2025 with a 35% share, projected to reach USD 72.80 million by 2034 at a CAGR of 6.31%, driven by demand for omega-rich and functional food products.

Top 5 Major Dominant Countries in Food Supplements Application

  • United States: USD 13.39 million in 2025, projected at USD 21.84 million by 2034 at 6.31% CAGR, driven by nutraceuticals adoption.
  • China: USD 8.93 million in 2025, forecasted at USD 14.56 million by 2034 at 6.31% CAGR, supported by dietary supplements growth.
  • Germany: USD 6.25 million in 2025, projected at USD 10.19 million by 2034 at 6.31% CAGR, fueled by health-focused diets.
  • Japan: USD 5.36 million in 2025, forecasted at USD 8.73 million by 2034 at 6.31% CAGR, led by functional foods.
  • South Korea: USD 4.46 million in 2025, projected at USD 7.28 million by 2034 at 6.31% CAGR, supported by wellness supplements.

Healthcare: Healthcare applications accounted for 20 percent of demand, equal to 3,700 metric tons in 2024. Asia-Pacific consumed 1,400 metric tons, North America 1,100, Europe 900, and Middle East & Africa 300.

Healthcare applications are forecasted at USD 25.50 million in 2025 with a 20% share, expected to reach USD 41.60 million by 2034 at a CAGR of 6.31%, driven by vaccines and pharmaceutical use of squalene.

Top 5 Major Dominant Countries in Healthcare Application

  • United States: USD 7.65 million in 2025, projected at USD 12.48 million by 2034 at 6.31% CAGR, supported by vaccine adjuvants.
  • China: USD 5.10 million in 2025, forecasted at USD 8.32 million by 2034 at 6.31% CAGR, driven by pharma growth.
  • Germany: USD 3.57 million in 2025, projected at USD 5.82 million by 2034 at 6.31% CAGR, fueled by healthcare research.
  • Japan: USD 3.06 million in 2025, forecasted at USD 4.99 million by 2034 at 6.31% CAGR, supported by pharmaceutical innovation.
  • India: USD 2.55 million in 2025, projected at USD 4.16 million by 2034 at 6.31% CAGR, driven by immunization programs.

Animal-sourced Squalene Market Regional Outlook

In 2024, Asia-Pacific led with 40 percent of consumption, equal to 7,400 metric tons, with China contributing 42 percent and Japan 21 percent of regional demand. Europe followed with 27 percent, or 5,000 metric tons, where Germany alone accounted for 22 percent. North America held 25 percent with 4,600 metric tons, 49 percent used in cosmetics, while Middle East & Africa represented 8 percent, or 1,500 metric tons, dominated by 53 percent demand from cosmetics and skincare.

Global Animal-sourced Squalene Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

NORTH AMERICA

North America accounted for 25 percent of global demand in 2024, equal to 4,600 metric tons. The U.S. represented 85 percent of regional consumption, Canada 10 percent, and Mexico 5 percent. Cosmetics accounted for 49 percent of demand, food supplements 34 percent, and healthcare 17 percent. Imports supplied 62 percent of U.S. usage, while domestic fisheries provided 38 percent. More than 70 cosmetic brands in the U.S. utilized squalene formulations in 2024.

North America is estimated at USD 44.64 million in 2025 with a 35% share, projected to reach USD 72.80 million by 2034 at a CAGR of 6.31%, supported by advanced cosmetic, nutraceutical, and healthcare industries.

North America - Major Dominant Countries in the Animal-sourced Squalene Market

  • United States: USD 31.25 million in 2025, projected at USD 51.00 million by 2034 at 6.31% CAGR, driven by healthcare and cosmetics.
  • Canada: USD 6.70 million in 2025, forecasted at USD 10.93 million by 2034 at 6.31% CAGR, supported by dietary supplements.
  • Mexico: USD 4.47 million in 2025, projected at USD 7.29 million by 2034 at 6.31% CAGR, fueled by cosmetic imports.
  • Cuba: USD 1.11 million in 2025, projected at USD 1.81 million by 2034 at 6.31% CAGR, supported by local healthcare.
  • Puerto Rico: USD 1.11 million in 2025, forecasted at USD 1.81 million by 2034 at 6.31% CAGR, led by cosmetic consumption.

EUROPE

Europe accounted for 27 percent of global demand in 2024, equal to 5,000 metric tons. Germany represented 22 percent of European consumption, France 18 percent, and Italy 15 percent. Food supplements accounted for 35 percent of demand, cosmetics 43 percent, and healthcare 22 percent. Over 600 European companies integrated squalene in food and pharmaceutical products in 2024. Regulatory restrictions impacted 35 percent of shark-derived imports.

Europe is valued at USD 38.26 million in 2025 with a 30% share, projected to reach USD 62.40 million by 2034 at a CAGR of 6.31%, supported by strong luxury cosmetics and pharmaceutical demand.

Europe - Major Dominant Countries in the Animal-sourced Squalene Market

  • Germany: USD 11.48 million in 2025, projected at USD 18.74 million by 2034 at 6.31% CAGR, led by pharma.
  • France: USD 9.18 million in 2025, forecasted at USD 14.98 million by 2034 at 6.31% CAGR, driven by cosmetics.
  • United Kingdom: USD 6.89 million in 2025, projected at USD 11.24 million by 2034 at 6.31% CAGR, supported by healthcare.
  • Italy: USD 5.74 million in 2025, forecasted at USD 9.36 million by 2034 at 6.31% CAGR, fueled by nutraceuticals.
  • Spain: USD 4.97 million in 2025, projected at USD 8.10 million by 2034 at 6.31% CAGR, driven by supplements.

ASIA-PACIFIC

Asia-Pacific accounted for 40 percent of global demand in 2024, equal to 7,400 metric tons. China represented 42 percent of regional consumption, Japan 21 percent, and India 18 percent. Cosmetics accounted for 43 percent of demand, food supplements 33 percent, and healthcare 24 percent. More than 1,200 cosmetic brands across Asia used squalene-based products in 2024. Over 22 percent of fisheries in the region operated under sustainability quotas.

Asia is projected at USD 38.26 million in 2025 with a 30% share, expected to reach USD 62.40 million by 2034 at 6.31% CAGR, supported by cosmetic, nutraceutical, and healthcare expansion in China, Japan, and South Korea.

Asia - Major Dominant Countries in the Animal-sourced Squalene Market

  • China: USD 11.48 million in 2025, projected at USD 18.74 million by 2034 at 6.31% CAGR, supported by cosmetic markets.
  • Japan: USD 7.65 million in 2025, forecasted at USD 12.48 million by 2034 at 6.31% CAGR, driven by pharmaceuticals.
  • India: USD 6.12 million in 2025, projected at USD 9.98 million by 2034 at 6.31% CAGR, supported by healthcare.
  • South Korea: USD 6.12 million in 2025, forecasted at USD 9.98 million by 2034 at 6.31% CAGR, fueled by K-beauty.
  • Indonesia: USD 4.90 million in 2025, projected at USD 7.99 million by 2034 at 6.31% CAGR, supported by supplements.

MIDDLE EAST & AFRICA

Middle East & Africa accounted for 8 percent of demand in 2024, equal to 1,500 metric tons. The UAE represented 26 percent of regional usage, Saudi Arabia 24 percent, and South Africa 18 percent. Cosmetics accounted for 53 percent of demand, food supplements 33 percent, and healthcare 14 percent. Regional imports accounted for 70 percent of supply due to limited fisheries.

Middle East and Africa are valued at USD 6.38 million in 2025 with a 5% share, projected to hit USD 10.40 million by 2034 at a CAGR of 6.31%, driven by cosmetics and healthcare adoption.

Middle East and Africa - Major Dominant Countries in the Animal-sourced Squalene Market

  • Saudi Arabia: USD 1.91 million in 2025, projected at USD 3.11 million by 2034 at 6.31% CAGR, led by cosmetic demand.
  • UAE: USD 1.28 million in 2025, forecasted at USD 2.08 million by 2034 at 6.31% CAGR, supported by healthcare.
  • South Africa: USD 1.02 million in 2025, projected at USD 1.66 million by 2034 at 6.31% CAGR, driven by nutraceuticals.
  • Egypt: USD 1.02 million in 2025, forecasted at USD 1.66 million by 2034 at 6.31% CAGR, fueled by pharma.
  • Nigeria: USD 1.02 million in 2025, projected at USD 1.66 million by 2034 at 6.31% CAGR, supported by healthcare.

List of Top Animal-sourced Squalene Companies

  • New Zealand Green Health
  • Seadragon Marine Oils
  • Arista Industries
  • Gracefruit
  • Kishimoto Special Liver Oil
  • Maruha Nichiro
  • Croda International
  • EFP Biotek
  • Amyris

Top two companies

with the highest market share: Maruha Nichiro accounted for 14 percent of global supply in 2024, equal to 2,600 metric tons. Seadragon Marine Oils followed with 12 percent, supplying 2,200 metric tons, primarily to Asia-Pacific and North America.

Investment Analysis and Opportunities

In 2024, 39 percent of investments targeted Asia-Pacific, 28 percent Europe, 24 percent North America, and 9 percent Middle East & Africa. Cosmetics represented 44 percent of new investments, food supplements 34 percent, and healthcare 22 percent. More than 1,500 patents were filed in 2023–2024, with 42 percent in extraction processes. Over 800 companies globally expanded production capacity, adding 4,000 metric tons annually. Sustainability initiatives accounted for 25 percent of investments, with new quotas ensuring 20 percent of shark-derived production transitioned to regulated fisheries.

New Product Development

Between 2023 and 2025, 40 percent of new products were cosmetics, 36 percent food supplements, and 24 percent healthcare. Asia-Pacific accounted for 41 percent of launches, Europe 29 percent, North America 24 percent, and Middle East & Africa 6 percent. New technologies increased purity from 95 percent to 98 percent. Seadragon Marine Oils introduced squalene with improved stability, reducing oxidation by 22 percent. Croda International launched healthcare-grade squalene for vaccines, used in over 25 percent of global adjuvant formulations.

Five Recent Developments

  • Global production reached 18,500 metric tons in 2024.
  • Asia-Pacific accounted for 7,400 metric tons, equal to 40 percent of global demand.
  • Maruha Nichiro supplied 2,600 metric tons, holding 14 percent of market share.
  • Over 1,500 patents were filed globally between 2023–2024.
  • Purity levels improved from 95 percent in 2022 to 98 percent in 2024.

Report Coverage

This Animal-sourced Squalene Market Market Report covers segmentation by type into C level at 56 percent of demand and director level at 44 percent. By application, cosmetics accounted for 47 percent of global demand, food supplements 33 percent, and healthcare 20 percent. Regionally, Asia-Pacific led with 40 percent, Europe 27 percent, North America 25 percent, and Middle East & Africa 8 percent. Key statistics include 18,500 metric tons of global production, 1,500 patents filed in 2023–2024, and over 800 companies expanding capacity. Forecasts extend to 2030, with a base year of 2024.

Animal-sourced Squalene Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 135.57 Million in 2026

Market Size Value By

USD 234.46 Million by 2035

Growth Rate

CAGR of 6.31% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • C Level
  • Director Level

By Application :

  • Cosmetics
  • Food Supplements
  • Healthcare

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Animal-sourced Squalene Market is expected to reach USD 234.46 Million by 2035.

The Animal-sourced Squalene Market is expected to exhibit a CAGR of 6.31% by 2035.

New Zealand Green Health,Seadragon Marine Oils,Arista Industries,Arista Industries,Gracefruit,Kishimoto Special Liver Oil,Maruha Nichiro,Croda International,EFP Biotek,Amyris.

In 2026, the Animal-sourced Squalene Market value stood at USD 135.57 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified